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Infectious diseases caused by drug-resistant microorganisms have become a major contributor for human morbidity and
mortality. To overcome such threats, we have developed various antimicrobial agents using natural product derivatives and
metallopolymers. Abundant biomass such as resin acids can be utilized to prepare cationic polymers for inhibiting a variety of
bacteria. These polymers have been used in solution as well as surfaces as antimicrobial materials with low cytotoxicity. In
addition, a class of charged metallopolymers have been developed to kill superbugs such as MRSA.

INTRODUCTION
The natural evolution of organisms has made the biosphere
exceptionally diverse. Although most of evolutionary events are
not evidently visible to us, an observable environmental evolution
is the adaptation of highly dynamic populations of microorganisms
such as bacteria toward antibiotics. Constant exposure of bacteria
to various classes of antimicrobials over the last few decades has
made a deadly army of multidrug-resistant bacteria, also called
superbugs, which threaten the wellbeing of humans worldwide.
Most antimicrobial agents target specific sites in the pathogen
cells, where many types of resist mechanisms are developed to
evade them (Figure 1).
Despite increasing occurrence of resistance, the discovery of
novel antimicrobial agents has a sluggish growth. Therefore, it is
urgent to explore new approaches to solving this pressing issue.
Among many targets of bacterial cells, the cell membrane is
thought to be a promising candidate that would have less likelihood
of developing resistance.2 Hydrophobic alkyl chain containing
cationic surfactants or detergents are membrane damaging agents
that are widely used for sterilizing purposes. However, most of
them show nonspecific toxicity towards mammalian cells and are
inefficient to selectively destroy multidrug-resistant bacteria. In
recent years, more attention is given to membrane-active cationic
antimicrobial polymers that show excellent antimicrobial activity
while maintaining negligible or no toxicity towards host cells.1, 3-5
In our research endeavors, we navigate two paths to develop
novel and effective antimicrobial agents with low toxicity. In one
approach, we utilize naturally occurring products such as resin
acids to make cationic polymers with tunable amphiphilicity to
selectively target bacterial membranes. On the other hand, we have
developed synthetic cationic metallopolymers (metal-containing
polymers) that could be conjugated with traditional antibiotics
against multidrug resistant bacteria. This short review summarizes
our own research efforts in innovating antimicrobial polymers
from the point view of a polymer laboratory.

Figure 1. (A) Typical antibiotic target sites present in bacterial
cells, and (B) mechanisms of antibiotic resistance. Reproduced
with permission from Elsevier. Copyright © 2015 Elsevier
Ltd.1
modified into a quaternary ammonium containing compound that
showed outstanding activity against a range of bacteria and high
selectivity against bacteria over mammalian cells.11 As shown in
Scheme 1, the synthesis involved a Diels–Alder reaction between
levopimaric acid and maleic anhydride to produce maleopimaric
acid, followed by amidation and quaternization reactions. This
cationic compound was used to functionalize an azide-containing
polycaprolactone polymer via azide-alkyne ‘click’ chemistry,
which resulted in a cationic polymer.
The antimicrobial activities of the resin acid-derived cationic
compounds and polymers were investigated against a range of
pathogenic and non-pathogenic microorganisms. The results
obtained for the disk-diffusion assays are shown in Figure 2.

Antimicrobials by Natural Resin Acids
Resin acids are abundant natural products mostly produced by
conifer trees in the form of oleoresin or rosin. The worldwide
production exceeds 1 million tons per year.6, 7 They consist of
diterpene-based acids such as abietic, levopimaric, and pimaric
acids. We have developed various types of resin acid-derived
polymers that showed excellent biodegradability and
biocompatibility as well as good mechanical properties.8-10 The
bulky hydrophenanthrene rings of resin acids serve as hydrophobic
building blocks that can be incorporated into the hydrophobic core
of bacterial lipid membranes. In one of the studies, abietic acid was

Scheme 1. Synthesis of quaternary ammonium-containing
resin acid-derived antimicrobial compounds and polymers.
Reproduced by permission of The Royal Society of
Chemistry.11
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Figure 2. Resin acid-derived antimicrobial materials against
various pathogens tested via a disk-diffusion method.
Minimum inhibitory concentrations for (A) Gram-positive and
(B) Gram-negative bacteria; (C) Images of agar plates obtained
from the disk-diffusion assay. TEAB = tetraethylammonium
bromide. Reproduced by permission of The Royal Society of
Chemistry.11
In a more recent study, the antimicrobial activity against
Methicillin-resistant Staphylococcus aureus (MRSA), a complex
of multidrug-resistant Gram-positive bacterial strains, was
evaluated.12 The results were unexpectedly promising with
minimum inhibitory concentrations as low as 5.0 µg/mL for the
cationic compound and 9.9 µg/mL for the polymer. The
biocompatibility of these resin-acid derived materials was tested
against mouse red blood cells and splenocytes. The results proved
that the cationic materials are largely non-toxic against mammalian
cells. Molecular dynamics simulations (Figure 3) and dye-leakage
assays indicated a membrane-lysing eﬀect. We believe that this is
induced by the unique fused ring structures of resin acids that may
be the underlying action for selective lysis of bacterial cells over
mammalian cells.
In the previous studies, the cationic charge was designed to
locate at the periphery of a polymer. The effect of the cationic
moiety located between the polymer backbone and the
hydrophobic rosin moiety on antimicrobial efficacy was also
investigated.13 These novel copolymers (PDMAEM-g-rosin) with
controlled molecular weight and narrow molecular weight
distribution were prepared via reversible-addition fragmentation
transfer (RAFT) polymerization and functionalized using
quaternization reactions. These cationic polymers exhibited
effective antibacterial activities against Escherichia coli and S.
aureus (Figure 4) with the activities dependent on both the degree
of quaternization of rosin group, the molecular weight of
copolymers as well as the conformation of hydrophobic group. In
a control study, PDMAEMA-g-eicosane having a linear alkyl
chain instead of the rosin moiety was used for the antimicrobial
assays. It showed no activity against E. coli and only exhibited
weak activity against S. aureus, suggesting that the activity of
PDMAEMA-g-rosin was due to not only the hydrophobicity of
rosin, but also its unique fused-ring structure.
Antibacterial, antibiofilm, and biocompatible properties of
surface-immobilized, quaternary ammonium-containing, resin
acid-derived compounds and polycations were recently reported
by our group.14 As shown in the Figure 5, the cationic compound
and its methacrylate monomer was prepared to modify surface of
a substrate.
Copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition click
reaction and surface-initiated atom transfer radical polymerization
were respectively used as chemical tools to graft compounds and

Figure 3. (A – D) Molecular dynamics simulations snapshots
of four stages depict cationic compound binding to lipid
molecules in the model anionic membrane; (E) the resin-acid
derived compound; (F) Plot of partial densities of lipid
phosphate head groups along the Z - axis, before and after
addition of the compound to the system. Reproduced by
permission of The Royal Society of Chemistry.12

Figure 4. FE-SEM images of E. coli (A, B) and S. aureus (C,
D) bacterial cells before (left) and after (right) treated with
PDMAEM-g-rosin copolymers. Loss of cellular integrity
indicated the damages to the cells resulted from the polymers.
Reproduced by permission of The Royal Society of
Chemistry.13

Figure 5. Surface modification with resin acid derived cationic
compounds and polymers. Reprinted with permission.14
Copyright (2015) American Chemical Society.
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polymers from the substrate surface. Antibacterial and antibiofilm
activities were tested against Gram-positive S. aureus and Gramnegative E. coli (Figure 6).
In addition to damaging bacteria that attach to the surfaces, these
modified surfaces damaged planktonic bacterial cells in solution
that came in contact with them. Furthermore, the biofilm growth
on these cationic surfaces was considerably reduced as
demonstrated by CDC bioreactor assays. An improved
proliferation of human fibroblast cells on the surfaces indicated
good biocompatibility of these coating materials.

More research will be carried out toward clinical applications of
these next-generation antimicrobial biomaterials.

Antimicrobials by Metal-Containing Polymers
Another major initiative in our laboratory is focused on synthetic
metallopolymers in both synthetic methodology and medicinal
chemistry. We discovered that cationic metallocene-containing
polymers and their bioconjugates with conventional antibiotics are
a new class of antimicrobial agents against multidrug-resistant
bacteria.15
Due to the exceptional ability of cationic
cobaltocenium moieties to complex with carboxylate anions,
cationic cobaltocenium-containing methacrylate polymers were
prepared and complexed with various β-lactam antibiotics,
including penicillin, ampicillin, amoxicillin, and cefazolin via ionpairing complexation (Figure 8). These conjugated
metallopolymers were tested against MRSA. Disc-diffusion assays
indicated that metallopolymers at a concentration of 1-2.2 µM and
most of the antibiotics alone showed very little inhibition, while
their bioconjugates exhibits significantly enhanced inhibition
against different strains of MRSA. Mechanistic investigation
revealed that these conjugated metallopolymers show high
efficiency in reducing β-lactamase activity and lyse bacterial cells
effectively. The β-lactamase enzyme and cell walls of the bacteria
are attacked by the metallopolymers, and at the same time, the
conjugated antibiotics are protected via forming ion-pairs with
cationic cobaltocenium-containing polymers (Figure 7).
These antibiotic-metallopolymer bioconjugates demonstrated
high resistance toward β-lactamase-induced hydrolysis and
significantly improved efficacy against various strains of MRSA
cells compared to conventional antibiotics. In addition, these
metallopolymers, at higher concentrations (≥ 5 µM), also showed
excellent antimicrobial activities against different strains of MRSA
by selectively disrupting bacterial cell membranes. Although these
cationic metallopolymers exhibited excellent efficiency against
multidrug-resistant MRSA, they showed negligible hemolytic
effects on red blood cells and minimal in vitro and in vivo toxicity.
In another study, we synthesized metallopolymer-containing
hydrogels (hydrogels are water swelling polymeric networks) for
healthcare applications.16 Cationic cobaltocenium-containing
hydrogels were tested for antimicrobial activities against various
bacteria, including drug-resistant strains. These hydrogels also had
the similar ability to disrupt negatively charged cell walls of
bacteria. We found that the metallopolymer hydrogel at a
concentration of 20 mg/mL showed inhibition of the growth of
Gram-negative E. coli (90% inhibition), Gram-positive S.
aureus (80% inhibition), and hospital-acquired methicillinresistant S. aureus (HA-MRSA, 80% inhibition). In addition,
these hydrogels were also capable of absorbing antibiotics from
contaminated water, due to the ability of cobaltocenium moieties
to bind with β-lactam antibiotics.

CONCLUSIONS
In summary, we demonstrated that pathogenic bacteria including
multidrug resistant superbugs can be effectively eliminated by
multiple strategies that we developed in a polymer laboratory.

Figure 6. Antimicrobial assay results. Stained (Live/Dead
stain) surfaces after 24 h incubation with (A) S. aureus and (B)
E. coli. Green cells indicate live bacteria colonizing the
surface, while dead cells appear in red color. S1: pristine
surface; S3: compound 1-grafted; and S5: polymer-grafted
surface. Reprinted with permission.14
Copyright (2015)
American Chemical Society.

Figure 7. Illustration of several key interactions involving βlactamase and β-lactam antibiotics. (A) MRSA cell surface;
(B) typical β-lactamase hydrolysis of β-lactam antibiotics;
and (C) Proposed interactions between β-lactam
antibiotic−metallopolymer bioconjugates, β-lactamase, and
cell wall. Reprinted with permission.15 Copyright (2015)
American Chemical Society.

Figure 8. (A) Formation of ion-pairs between β-lactam
antibiotics and cationic cobaltocenium-containing polymers;
(B) Four β-lactam antibiotics used in this study; (C) Antibiotic
release from antibiotic-metallopolymer ion-pairs via
lipoteichoic acid or β-lactamases. Reprinted with permission.15
Copyright (2015) American Chemical Society.
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